AN2 Therapeutics
ANTX
NASDAQ
IPO2022
about ANTX
AN2 Therapeutics develops innovative treatments in immunology and oncology, leveraging cutting-edge biotechnology to address significant medical needs.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $3.02 | $6.91 | $2.97 | $78.10M | 57.96M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.31 | n/a | n/a | 0% | 0% | 51.07% |